๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer

โœ Scribed by Sagawa, M; Saito, Y; Fujimura, S; Linnoila, RI

Book ID
109837494
Publisher
Nature Publishing Group
Year
1998
Tongue
English
Weight
830 KB
Volume
77
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

K-ras mutation in sputum of patients wit
K-ras mutation in sputum of patients with or without lung cancer
โœ Ze'ev Ronai; Marina S. Yabubovskaya; Edith Zhang; Gennady A. Belitsky ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 493 KB ๐Ÿ‘ 2 views

K-ras mutation appears in about 60% of patients with non-small-cell lung cancer (NSCLC). This freqLency and its presence in normal appearing tissues point to the potential of ras oncogene mutation to serve as a good biomarker. Using enriched PCR (EPCR), which enables the detection of one mutant alle

Lack of ฮฒ-tubulin gene mutations in earl
Lack of ฮฒ-tubulin gene mutations in early stage lung cancer
โœ Maija R.J. Kohonen-Corish; Han Qin; Joseph J. Daniel; Wendy A. Cooper; Laurent R ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 55 KB

## Dear Sir, Lung cancer causes the most cancer-related deaths in western countries and its treatment remains a challenge. Encouraging results have been obtained recently with new chemotherapeutic agents such as paclitaxel in non-small-cell lung cancer. A striking association, however, has been re